Prolonged bleeding time associated with moxalactam administration

L. Fishman; W. R. Marsh

doi:10.1227/00006123-198406000-00015

Prolonged bleeding time associated with moxalactam administration

L. Fishman, W. R. Marsh

Neurosurgery

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

A case of moxalactam-induced coagulopathy is reported. The authors think that this coagulopathy is caused by an effect on platelet aggregation and not by inhibition of vitamin K-dependent clotting factors. It is recommended that bleeding times be routinely checked preoperatively in patients being treated with moxalactam.

Original language	English (US)
Pages (from-to)	735-736
Number of pages	2
Journal	Neurosurgery
Volume	14
Issue number	6
DOIs	https://doi.org/10.1227/00006123-198406000-00015
State	Published - 1984

ASJC Scopus subject areas

Surgery
Clinical Neurology

Access to Document

10.1227/00006123-198406000-00015

Cite this

@article{27d126a883084fed9812cd22619da987,

title = "Prolonged bleeding time associated with moxalactam administration",

abstract = "A case of moxalactam-induced coagulopathy is reported. The authors think that this coagulopathy is caused by an effect on platelet aggregation and not by inhibition of vitamin K-dependent clotting factors. It is recommended that bleeding times be routinely checked preoperatively in patients being treated with moxalactam.",

author = "L. Fishman and Marsh, {W. R.}",

year = "1984",

doi = "10.1227/00006123-198406000-00015",

language = "English (US)",

volume = "14",

pages = "735--736",

journal = "Neurosurgery",

issn = "0148-396X",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Prolonged bleeding time associated with moxalactam administration

AU - Fishman, L.

AU - Marsh, W. R.

PY - 1984

Y1 - 1984

N2 - A case of moxalactam-induced coagulopathy is reported. The authors think that this coagulopathy is caused by an effect on platelet aggregation and not by inhibition of vitamin K-dependent clotting factors. It is recommended that bleeding times be routinely checked preoperatively in patients being treated with moxalactam.

AB - A case of moxalactam-induced coagulopathy is reported. The authors think that this coagulopathy is caused by an effect on platelet aggregation and not by inhibition of vitamin K-dependent clotting factors. It is recommended that bleeding times be routinely checked preoperatively in patients being treated with moxalactam.

UR - http://www.scopus.com/inward/record.url?scp=0021233511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021233511&partnerID=8YFLogxK

U2 - 10.1227/00006123-198406000-00015

DO - 10.1227/00006123-198406000-00015

M3 - Article

C2 - 6462409

AN - SCOPUS:0021233511

SN - 0148-396X

VL - 14

SP - 735

EP - 736

JO - Neurosurgery

JF - Neurosurgery

IS - 6

ER -

Prolonged bleeding time associated with moxalactam administration

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this